Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hydrogen water shows promise for metabolic syndrome in small trial

NCT ID NCT06968715

Disease control Sponsor: University of Novi Sad, Faculty of Sport and Physical Education Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether drinking hydrogen-rich water every day for 12 weeks can improve body composition and metabolic health in adults with metabolic syndrome. 40 adults participated, and researchers measured changes in waist size, body fat, blood sugar, and cholesterol. The goal was to see if this simple drink could help control the condition and identify who might benefit most.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Apr 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 30-65 years * Metabolic syndrome (NHS) (at least 3 of the 5 following criteria): * Waist circumference of ≥ 102 cm in men and ≥ 88 cm in women * Hypertriglyceridemia (≥ 1.695 mmol/L) * Low HDL-C (\< 1.04 mmol/dL in men and \< 1.30 mmol/dL in women) * High blood pressure (\> 130/85 mmHg) * High fasting glucose (\> 6.1 mmol/L) * Not physically active * Informed consent signed Exclusion Criteria: * Major chronic disease and acute injuries * History of dietary supplement use during the past 4 weeks * History of metabolism-modulating pharmaceuticals use during the past 4 weeks * No consent to randomization * Participation in other studies

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metabolic syndrome are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome metabolic syndrome X

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Metabolic syndrome

Contacts and locations

Locations

  • Applied Bioenergetics Lab at Faculty of Sport and PE

    Novi Sad, Vojvodina, 21000, Serbia

More trials for these conditions

Other studies related to the condition(s) this trial covers.